A US federal court rules that procedures in which a patient's own stem cells are extracted, manipulated, and reinjected should be regulated by the FDA.
Daily News Roundup
A US federal court rules that procedures in which a patient's own stem cells are extracted, manipulated, and reinjected should be regulated by the FDA.
After years of complaints, the European Commission proposes ways to fix its system in an effort to reinvigorate research on the continent.
Research and funding organizations pledge to support a new system to support cross-border collaboration within the European Union.
Starting in April 2013, research supported by the United Kingdom government must be made freely available within 6 months of publication.
The researcher who raised questions about the studies by social psychologist Dirk Smeesters flags dodgy data from another scientist.
The new law reauthorizes fees charged to drug and device makers, creates new fees for the approval of generic drugs.
According to a new report, the US Fish and Wildlife Service ignored science advisors and shrunk protected habitats for endangered species from 2002 to 2007.
A researchers in Japan faked patient data on nearly 200 studies over the past 2 decades, according to an investigating committee.
An advisory committee urges the federal funding agency to take steps to counter racial bias in the granting process.
A public interest legal group has renewed the fight against DNA patenting.